Brandon R. Theiss

Federal Circuit Clarifies Obviousness-Type Double Patenting In Allergan V. MSN Laboratories: The Impact Of Patent Term Adjustments On First-Filed Patents

Getting HIP With Inventorship

"At Least One Of" Revisited: Arguing SuperGuide As A Basis For Patent Validity

Director Vidal Further Clarifies When A Discretionary Denial Of An IPR Is Appropriate Under Fintiv

Discretionary Denials Under Fintiv Rebooted By Vidal's Decision

A Different State Of Mind: Getting Technical With Post-Grant Proceedings Before The PTAB